<DOC>
	<DOCNO>NCT01282437</DOCNO>
	<brief_summary>For patient stage III non-small cell lung cancer , radically treat , investigate whether prophylactic cranial irradiation ( PCI ) become standard care prevent brain metastasis .</brief_summary>
	<brief_title>Prophylactic Cranial Irradiation ( PCI ) v Observation Stage III NSCLC</brief_title>
	<detailed_description>For group patient , brain metastasis one major site tumor failure . Radical therapy symptomatic brain metastasis seldom possible rarely , long term survival achieve . PCI show reduce incidence brain metastases patient non-small cell lung cancer extent limit disease small-cell lung cancer . However , exact value PCI stage III NSCLC patient , treat contemporary chemo-radiation schedule without surgery , remain unsettled . Therefore study launch , order investigate whether PCI become standard care patient stage III NSCLC treat curative intention .</detailed_description>
	<mesh_term>Lung Neoplasms</mesh_term>
	<mesh_term>Carcinoma , Non-Small-Cell Lung</mesh_term>
	<criteria>UICC stage IIIA IIIB ( without malignant pleural pericardial effusion ) nonsmall cell lung cancer ( histology cytology ) Whole body FDGPETscan start therapy available : No distant metastasis CT MRI brain start radical therapy available : No brain metastasis Platinumbased chemotherapy mandatory Radical local therapy : concurrent sequential chemotherapy ( platinumbased ) radiotherapy without surgery Radiotherapy dose without surgery least biological equivalent 60Gy No prior cranial irradiation Patients must sign studyspecific inform consent time registration The opposite</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>April 2015</verification_date>
</DOC>